BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36093087)

  • 1. Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy.
    Lin B; Zhao F; Liu Y; Sun J; Feng J; Zhao L; Wang H; Chen H; Yan W; Guo X; Shi S; Li Z; Wang S; Lu Y; Zheng J; Wei Y
    Front Endocrinol (Lausanne); 2022; 13():895970. PubMed ID: 36093087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.
    Klein Hesselink EN; Brouwers AH; de Jong JR; van der Horst-Schrivers AN; Coppes RP; Lefrandt JD; Jager PL; Vissink A; Links TP
    J Nucl Med; 2016 Nov; 57(11):1685-1691. PubMed ID: 27339871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
    Jeong SY; Kim HW; Lee SW; Ahn BC; Lee J
    Thyroid; 2013 May; 23(5):609-16. PubMed ID: 23153322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: A prospective comparative study.
    da Fonseca FL; Yamanaka PK; Mazoti L; Arakawa-Sugueno L; Kato JM; Matayoshi S
    Head Neck; 2017 Dec; 39(12):2381-2396. PubMed ID: 28945293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.
    Bohuslavizki KH; Klutmann S; Brenner W; Kröger S; Buchert R; Bleckmann C; Mester J; Henze E; Clausen M
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():6-12. PubMed ID: 10584133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of salivary gland dysfunction in patients treated with radioiodine for differentiated thyroid cancer: A systematic review of randomized controlled trials.
    Auttara-Atthakorn A; Sungmala J; Anothaisintawee T; Reutrakul S; Sriphrapradang C
    Front Endocrinol (Lausanne); 2022; 13():960265. PubMed ID: 36105397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer.
    Bohuslavizki KH; Klutmann S; Bleckmann C; Brenner W; Lassmann S; Mester J; Henze E; Clausen M
    Strahlenther Onkol; 1999 Feb; 175(2):57-61. PubMed ID: 10065139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioactive iodine: An unappreciated threat to salivary gland function.
    Sunavala-Dossabhoy G
    Oral Dis; 2018 Mar; 24(1-2):198-201. PubMed ID: 29480611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying postoperative radioiodine therapy before 3 months seems to decrease ablation success in patients with differentiated thyroid carcinoma.
    Özdoğan Ö; Aksu A; Doğan E; Bülbül O; Güray Durak M; Sevinç Aİ; Bayraktar F; İkiz AÖ
    Ann Nucl Med; 2021 Feb; 35(2):223-231. PubMed ID: 33389664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Clinical Trial: Probiotics Alleviated Oral-Gut Microbiota Dysbiosis and Thyroid Hormone Withdrawal-Related Complications in Thyroid Cancer Patients Before Radioiodine Therapy Following Thyroidectomy.
    Lin B; Zhao F; Liu Y; Wu X; Feng J; Jin X; Yan W; Guo X; Shi S; Li Z; Liu L; Chen H; Wang H; Wang S; Lu Y; Wei Y
    Front Endocrinol (Lausanne); 2022; 13():834674. PubMed ID: 35350100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary evaluation in radioactive I
    Daniel FI; Lima LD; Grando LJ; Castro R; Cordeiro EAK; Dos Santos CR
    Acta Odontol Scand; 2018 Mar; 76(2):148-152. PubMed ID: 29125000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct shifts in the oral microbiota are associated with the progression and aggravation of mucositis during radiotherapy.
    Hou J; Zheng H; Li P; Liu H; Zhou H; Yang X
    Radiother Oncol; 2018 Oct; 129(1):44-51. PubMed ID: 29735410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long-term study.
    Le Roux MK; Graillon N; Guyot L; Taieb D; Galli P; Godio-Raboutet Y; Chossegros C; Foletti JM
    Head Neck; 2020 Nov; 42(11):3133-3140. PubMed ID: 32652742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy.
    Solans R; Bosch JA; Galofré P; Porta F; Roselló J; Selva-O'Callagan A; Vilardell M
    J Nucl Med; 2001 May; 42(5):738-43. PubMed ID: 11337569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey.
    Reiners C; Schneider R; Platonova T; Fridman M; Malzahn U; Mäder U; Vrachimis A; Bogdanova T; Krajewska J; Elisei R; Vaisman F; Mihailovic J; Costa G; Drozd V
    Front Endocrinol (Lausanne); 2020; 11():381. PubMed ID: 32754115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of radioiodine treatment on salivary gland function in adult survivors of pediatric differentiated thyroid carcinoma.
    Selvakumar T; Nies M; Klein Hesselink MS; Brouwers AH; van der Horst-Schrivers ANA; Klein Hesselink EN; Tissing WJE; Vissink A; Links TP; Bocca G; Burgerhof JGM; van Dam EWCM; Havekes B; van den Heuvel-Eibrink MM; Corssmit EPM; Kremer LCM; Netea-Maier RT; van der Pal HJH; Peeters RP; Smit JWA; Plukker JTM; Ronckers CM; van Santen HM
    J Nucl Med; 2018 Nov; ():. PubMed ID: 30504138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialendoscopy for Patients with Radioiodine-Induced Sialadenitis and Xerostomia.
    Bhayani MK; Acharya V; Kongkiatkamon S; Farah S; Roberts DB; Sterba J; Chambers MS; Lai SY
    Thyroid; 2015 Jul; 25(7):834-8. PubMed ID: 25860842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sialendoscopy on improving health related quality of life in patients suffering from radioiodineinduced xerostomia.
    Bulut OC; Haufe S; Hohenberger R; Hein M; Kratochwil C; Rathke H; Plinkert PK; Baumann I; Holland-Letz T; Haberkorn U; Flechsig P
    Nuklearmedizin; 2018 Aug; 57(4):160-167. PubMed ID: 30125928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current literature.
    Zhang X; Liu DS; Luan ZS; Zhang F; Liu XH; Zhou W; Zhong SF; Lai H
    Clin Transl Oncol; 2018 Jul; 20(7):928-935. PubMed ID: 29119458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.